These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8442259)

  • 1. Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss.
    David-Neto E; Ribeiro DS; Ianhez LE; Palomino S; Saldanha LB; Arap S; Sabbaga E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):897-9. PubMed ID: 8442259
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
    Olsen S; Hansen HE
    Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistological study of a pediatric patient with plasma cell-rich acute rejection.
    Chikamoto H; Sugawara N; Akioka Y; Shimizu T; Horita S; Honda K; Moriyama T; Koike J; Yamaguchi Y; Hattori M
    Clin Transplant; 2012 Jul; 26 Suppl 24():54-7. PubMed ID: 22747477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose dexamethasone--an alternative therapy for acute renal allograft rejection.
    Kher V; Kohli HS; Mishra V; Sharma RK; Bhandari M
    Transplant Proc; 1992 Oct; 24(5):1725. PubMed ID: 1412812
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of acute antibody-mediated rejection in renal allograft biopsies.
    Kanodia KV; Vanikar AV; Trivedi HL
    Transplant Proc; 2008 May; 40(4):1099-103. PubMed ID: 18555123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A; Solez K; Poppema S; Cockfield S; Rayner D
    Transplant Proc; 1996 Feb; 28(1):482-3. PubMed ID: 8644320
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of interstitial lesions as the early indicator for acute vascular rejection in human renal allografts.
    Saisu K; Morozumi K; Suzuki K; Fujita K
    Clin Transplant; 1999; 13 Suppl 1():17-23. PubMed ID: 10751052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
    Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
    Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 19. Mast cells in acute cellular rejection of human renal allografts.
    Lajoie G; Nadasdy T; Laszik Z; Blick KE; Silva FG
    Mod Pathol; 1996 Dec; 9(12):1118-25. PubMed ID: 8972470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings of the 12th Clinicopathological Conference on Renal Allograft Pathology, 19 July 2008, Tokyo, Japan. Introduction.
    Hattori M
    Clin Transplant; 2009 Aug; 23 Suppl 20():1. PubMed ID: 19594586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.